N-(6,7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

N-(6,7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

● Auf Lager

Katalog-Nr.::VE0022768
CAS-Nr.::N/A
Summenformel::C17H15N3O4
Molare Masse::325.32 g/mol

Zusätzliche Informationen zu N-(6 | 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

Parent drug

Cabozantinib

IUPAC-Name

N-(6, 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

OC1=CC=C(N(C2=CC=NC3=C2C=C(OC)C(OC)=C3)N=O)C=C1

InChI

InChI=1S/C17H15N3O4/c1-23-16-9-13-14(10-17(16)24-2)18-8-7-15(13)20(19-22)11-3-5-12(21)6-4-11/h3-10, 21H, 1-2H3

Beschreibung

The compound N-(6 | 7-dimethoxyquinolin-4-yl)-N-(4-hydroxyphenyl)nitrous amide is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Cabozantinib. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url